{
  "main_header": {
    "sid": 1003715,
    "name": "Trident Lifeline",
    "stock_name": "Trident Lifeline",
    "full_name": "Trident Lifeline Ltd",
    "name_url": "stocks-analysis/trident-lifeline",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "248.15",
    "chg": -12.85,
    "chgp": "-4.92%",
    "dir": -1,
    "prev_price": "261.00",
    "mcapval": "285.35 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543616,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE0MKA01014",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:09 AM",
    "bse_nse_vol": 2400,
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trident-lifeline-1003715-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Trident Lifeline Reports Strong Growth Amid Cautious Stock Outlook in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-stock-downgraded-to-sell-despite-positive-financial-performance-1058965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TridentLifeline_mojoScore_475326.png",
        "date": "2025-02-19 19:06:04",
        "description": "Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has reported strong financial results for the third quarter of FY24-25, with net sales reaching Rs 46.91 crore and profit after tax at Rs 9.43 crore. The company has shown consistent growth over the past three quarters."
      },
      {
        "title": "Trident Lifeline Reports Strong Growth and Low Debt Amid Market Evaluation Adjustments",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-reports-82-81-net-sales-growth-and-123-46-pat-increase-in-november-2024-994822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TridentLifeline_mojoScore_423036.png",
        "date": "2025-02-12 18:57:00",
        "description": "Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid strong financial performance for Q3 FY24-25. The company reported a 43.10% increase in net sales and a 57.52% rise in operating profit, maintaining a low debt-to-equity ratio and consistent growth over three quarters."
      },
      {
        "title": "Trident Lifeline Reports Strong Q3 Growth Amid Complex Valuation Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-faces-sell-downgrade-despite-strong-q3-fy24-25-financial-performance-787002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TridentLifeline_mojoScore_396434.png",
        "date": "2025-02-07 18:58:58",
        "description": "Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, recently reported strong third-quarter results for FY24-25, highlighting a significant annual growth in net sales and operating profit. The company has shown consistent positive performance over the past year, significantly outperforming the broader market."
      },
      {
        "title": "Trident Lifeline Reports Strong Q3 Growth Amidst Market Evaluation Adjustments",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-reports-43-10-net-sales-growth-in-q3-fy24-25-upgraded-to-hold-rating-2-748595",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TridentLifeline_mojoScore_334311.png",
        "date": "2025-02-01 18:43:58",
        "description": "Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has reported strong financial performance, with a 43.10% increase in net sales and a 57.52% rise in operating profit for Q3 FY24-25. The company has shown consistent growth, achieving an 89.01% rise in half-year net sales."
      }
    ],
    "total": 42,
    "sid": "1003715",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/trident-lifeline-1003715"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consider And Approve The Proposal To Raise Funds At The Board Meeting To Be Held On April 16 2025",
      "datetime": "09-Apr-2025",
      "details": "Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 inter alia to consider and approve the proposal to raise fund by way of issue of equity shares/convertible warrants",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2025",
      "details": "Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from April 01 2025 and shall re-open 48 (Forty-Eight) hours from the conclusion of the Meeting of the Board of Directors to be held for the purpose of considering the Audited Financial Results (standalone and consolidated) for the quarter and Year ended March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of LODR- Cessation Of Step-Down Subsidiary Company",
      "datetime": "27-Mar-2025",
      "details": "Intimation of the cessation of step-down subsidiary T-Med Biovation Private Limited pursuant to dis-investment by the subsidiary of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Trident Lifeline Reports Strong Growth Amid Cautious Stock Outlook in Pharmaceuticals Sector

2025-02-19 19:06:04

Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has reported strong financial results for the third quarter of FY24-25, with net sales reaching Rs 46.91 crore and profit after tax at Rs 9.43 crore. The company has shown consistent growth over the past three quarters.

Read More

Trident Lifeline Reports Strong Growth and Low Debt Amid Market Evaluation Adjustments

2025-02-12 18:57:00

Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid strong financial performance for Q3 FY24-25. The company reported a 43.10% increase in net sales and a 57.52% rise in operating profit, maintaining a low debt-to-equity ratio and consistent growth over three quarters.

Read More

Trident Lifeline Reports Strong Q3 Growth Amid Complex Valuation Metrics

2025-02-07 18:58:58

Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, recently reported strong third-quarter results for FY24-25, highlighting a significant annual growth in net sales and operating profit. The company has shown consistent positive performance over the past year, significantly outperforming the broader market.

Read More

Trident Lifeline Reports Strong Q3 Growth Amidst Market Evaluation Adjustments

2025-02-01 18:43:58

Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has reported strong financial performance, with a 43.10% increase in net sales and a 57.52% rise in operating profit for Q3 FY24-25. The company has shown consistent growth, achieving an 89.01% rise in half-year net sales.

Read More

View All News